CIK 0000842023 · Large accelerated filer
BIO-TECHNE Corp
Sign in to watch- Ticker
- TECH
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jun 30
- Incorporated
- MN
- Entity type
- operating
- EIN
- 411427402
- Phone
- 612-379-8854
- Business address
- 614 MCKINLEY PLACE NE, MINNEAPOLIS, MN
- Former names
- TECHNE CORP /MN/
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-11-09 | Hippel James Chief Financial Officer | Sale | −1,002 | $311.60 | $312K | 9,437 |
| 2020-11-09 | Hippel James Chief Financial Officer | Sale | −300 | $312.58 | $94K | 9,137 |
| 2020-11-09 | Hippel James Chief Financial Officer | Option exercise · Stock Options (Right to Buy) | −3,600 | 67,333 | ||
| 2020-11-06 | STEER RANDOLPH C Director | Option exercise | +5,000 | $70.35 | $352K | 10,112 |
| 2020-11-06 | STEER RANDOLPH C Director | Option exercise | +5,000 | $66.90 | $335K | 15,112 |
| 2020-11-06 | STEER RANDOLPH C Director | Sale | −1,723 | $299.06 | $515K | 13,389 |
| 2020-11-06 | STEER RANDOLPH C Director | Sale | −1,771 | $299.96 | $531K | 11,618 |
| 2020-11-06 | STEER RANDOLPH C Director | Sale | −1,801 | $301.78 | $544K | 9,817 |
| 2020-11-06 | STEER RANDOLPH C Director | Sale | −1,195 | $302.31 | $361K | 8,622 |
| 2020-11-06 | STEER RANDOLPH C Director | Sale | −975 | $304.14 | $297K | 7,647 |
| 2020-11-06 | STEER RANDOLPH C Director | Sale | −2,535 | $304.59 | $772K | 5,112 |
| 2020-11-06 | STEER RANDOLPH C Director | Option exercise · Stock Option (Right to Buy) | −5,000 | 0 | ||
| 2020-11-06 | STEER RANDOLPH C Director | Option exercise · Stock Option (Right to Buy) | −5,000 | 0 | ||
| 2020-11-06 | HIGGINS JOHN L Director | Option exercise | +5,000 | $70.35 | $352K | 9,412 |
| 2020-11-06 | HIGGINS JOHN L Director | Sale | −1,450 | $298.98 | $434K | 7,962 |
| 2020-11-06 | HIGGINS JOHN L Director | Sale | −450 | $299.84 | $135K | 7,512 |
| 2020-11-06 | HIGGINS JOHN L Director | Sale | −3,100 | $301.06 | $933K | 4,412 |
| 2020-11-06 | HIGGINS JOHN L Director | Option exercise · Stock Option (Right to Buy) | −5,000 | 0 | ||
| 2020-11-06 | Kummeth Charles R. Chief Executive Officer | Option exercise | +25,157 | $86.25 | $2.2M | 186,644 |
| 2020-11-06 | Kummeth Charles R. Chief Executive Officer | Shares withheld for taxes | −15,375 | $302.47 | $4.7M | 171,269 |
Page 38 of 53 · 1,043 trades